Skip to content
healthcare.dev
Get a free key

Target Eye Drops Maximum Redness Relief Eye

NDC 11673-100, Glycerin, Naphazoline hydrochloride, solution/ drops, from Target Corporation.

Product NDC
11673-100
Status
Listed
Labeler
Target Corporation
Dosage form
SOLUTION/ DROPS
Route
OPHTHALMIC
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M018
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11673-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCERIN500 mg/100mL
  • NAPHAZOLINE HYDROCHLORIDE30 mg/100mL

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
11673-100-01116730100011 BOTTLE, DROPPER in 1 BOX (11673-100-01) / 15 mL in 1 BOTTLE, DROPPER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 11673-100 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11673-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11673-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.